Approvals/NMPA/Recombinant B-subunit/Whole Cell Cholera Vaccine（Enteric-coated Capsule）

Approved

生物制品

Recombinant B-subunit/Whole Cell Cholera Vaccine（Enteric-coated Capsule）

上海联合赛尔生物工程有限公司🇨🇳 National Medical Products Administration

Approval Id: 7LeaeNiq02U
Approval Number: 国药准字S20133005
Generic Name: 重组B亚单位/菌体霍乱疫苗(肠溶胶囊)
Generic Name En: Recombinant B-subunit/Whole Cell Cholera Vaccine（Enteric-coated Capsule）
Trade Name: 可唯适
Brand Name: 可唯适
Drug Type: 生物制品
Dosage Form: 胶囊剂
Strength: 每粒胶囊装量240mg,含灭活霍乱弧菌5.0×10[10]个,重组霍乱毒素B亚单位1mg。配套抗酸剂每袋装量3g(供2-6岁儿童用)。
Reg Date: 2019-12-31
Company Name: 上海联合赛尔生物工程有限公司
Company Address: 中国（上海）自由贸易试验区桂桥路1150号
Production Company Name: 上海联合赛尔生物工程有限公司
Production Company Address: 中国（上海）自由贸易试验区桂桥路1150号
Company Detail Path: /organization/shang-hai-lian-he-sai-er-sheng-wu-gong-cheng-you-xian-gong-si
Production Company Detail Path: /organization/shang-hai-lian-he-sai-er-sheng-wu-gong-cheng-you-xian-gong-si

Approved

Agency

NMPA

Country

🇨🇳

Approval Date

Dec 31, 2019

Approval ID

7LeaeNiq02U

Type

生物制品